Clinical Trial Update: Randomized, Open, Parallel, Active Controlled Study on Fracture Prevention in Antiosteoporosis Treatment (OF Study) [Phase 4]

View source ↗

Summary

A completed Phase 4 randomized, open, parallel, active-controlled trial evaluating fracture prevention in osteoporosis treatment sponsored by Eisai Limited.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoporosis

Snippet

Sponsor: Eisai Limited | Conditions: Osteoporosis | Phase 4 | Status: COMPLETED